Stock Events

Regeneron Pharmaceuticals (REGN) Q4 2023 Earnings

2NovConfirmed
Q1 2023
Q2 2023
Q3 2023
Q4 2023
9.61
10.59
11.58
12.56

Details

Expected EPS
10.68
Actual EPS
11.59
Surprise EPS
0.91
Surprise Percent
+8.52%

Description

Regeneron Pharmaceuticals (REGN) has reported earnings of 11.59 per share for Q4 2023.

0 Comments

Share your thoughts